Le Lézard
Classified in: Science and technology
Subject: Personnel

Piper Sandler Promotes Brian White to Co-Head of Technology Investment Banking


Piper Sandler Companies (NYSE: PIPR), a leading investment bank, today announced that effective immediately, Brian White has been appointed co-head of technology investment banking, joining Steven Schmidt, who shares the same title. White assumes the role from Nicholas Osborne, who will become chairman of technology investment banking and focus on clients and driving revenue and growth for the firm.

"Brian is a great leader and an exceptional banker who has built a strong security and defense technology practice over the years. We are excited for him to join Steve as they continue to expand our technology business which is a key priority for the firm. I would also like to thank Nick for the tremendous job he did seamlessly integrating and leading our technology investment banking team since we acquired DBO Partners," said Mike Dillahunt, global co-head of investment banking and capital markets at Piper Sandler.

Prior to joining the firm, White was a partner at DBO Partners where he focused on security and defense technology and infrastructure software. Before DBO Partners, he served as president of, and COO of RedOwl, a cybersecurity company acquired by Forcepoint in 2017. Previously, White was a partner at the Chertoff Group where he established the company's West Coast technology advisory and investment banking practice. Prior to the Chertoff Group, he served as a senior official at the Department of Homeland Security. White graduated with a bachelor's and master's degree from Syracuse University.

"Piper Sandler has a strong history of technology M&A and capital markets leadership and I am thrilled to have the opportunity to help propel us forward into our next phase of growth. The acquisition of DBO Partners enhanced our existing technology presence and we intend to accelerate the growth of the platform across the technology ecosystem," said White.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2024. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: